Phage therapy takes on superbug UTIs in new trial
Disease control
Recruiting now
This study tests a new treatment called LBP-EC01, which uses specially designed viruses (bacteriophages) to attack drug-resistant E. coli bacteria that cause urinary tract infections (UTIs). About 318 adults with a history of UTIs and a current infection will receive either LBP-E…
Phase: PHASE2 • Sponsor: Locus Biosciences • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC